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Summary
Background: Poor communication of drug therapy at care interface often results in
medication errors and adverse drug events. Medication reconciliation has been introduced
as a measure to improve continuity of patient care. The aim of this cross-sectional
observational study was to evaluate the need for medication reconciliation.
Methods: Comprehensive information on pre-admission therapy was obtained by a research
pharmacist for adult medical patients, admitted to a teaching hospital, specialised in
pulmonary and allergic diseases, in Slovenia. This information was compared with the in-
patient and discharge therapies to identify unintentional discrepancies (medication errors)
whose clinical signiﬁcance was determined by an expert panel reaching consensus.
Results: Most of the included 101 patients were elderly (median age: 73 years) who
had multiple medications. Among their in-patient drugs (880), few discrepancies were
a medication error (54/654), half of which were judged to be clinically important. A
higher rate was observed in the discharge drug therapy (747): 369 of the identiﬁed
discrepancies (566) were a medication error, over half of which were judged as clinically
important. A greater number of pre-admission drugs, poorly taken medication histories
and a greater number of medication errors in in-patient therapy predisposed patients to
clinically important medication errors in discharge therapy.
Conclusions: This study provided evidence in a small sample of patients on the
discontinuity of drug therapy at patient discharge in a hospital in Slovenia and its
implications for patient care. To ensure continuity and safety of patient care, medication
reconciliation should be implemented throughout a patient’s hospital stay.
© 2011 Elsevier Ltd. All rights reserved.
Introduction
With the ageing of population, the average patient has
multiple diseases and is treated with multiple medications,
predisposing patients to a higher risk for adverse drug
events (ADE).1–4 Poor communication at points of patient
transfer further potentiates the risk for medication errors
(ME) and ADEs when patients move across the healthcare
interface.5–18 At hospital admission, at least one ME was
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present in up to 67% of patients and almost 60% of the errors
had the potential to cause harm.5 At hospital discharge,
at least one unexplained change in pre-admission therapy
was present in nearly half of patients and caused an ADE
in 11% of patients where medication reconciliation services
were not applied.8 It is important to differentiate between
MEs and ADEs. An ME is deﬁned as any preventable event
that may cause or lead to inappropriate medication use or
patient harm, whereas an ADE is an actual untoward medical
event that occurs during treatment with a pharmaceutical
product.19,20 Thus, an ME can but does not always result in
an ADE.
The aforementioned facts emphasize the importance of
keeping accurate and complete medication histories for safe
0954-6111$ – see front matter © 2011 Elsevier Ltd. All rights reserved.
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patient care. However, many situations in everyday clinical
practice threaten the accuracy and integrity of obtained
medication histories.12,14,17
Poor medication history taking can lead to discrepancies
between patients’ pre-admission and in-patient therapy.
These discrepancies may have no professional intent
(unintentional discrepancies) or may be done with a
professional intent (intentional discrepancies) as changes in
drug therapy are required due to a patient’s condition or
treatment goals.17 Although only unintentional discrepancies
can be classiﬁed as medication errors, also intentional
discrepancies in an in-patient therapy may lead to errors
in the discharge therapy as an intentionally, but only
temporally discontinued drug might not be restarted at
discharge.6,17
These discrepancies have important implications for the
continuity of patient care and, most importantly, patient
safety.9 Medication reconciliation, deﬁned as the process
of verifying medication use, identifying variances, and
preventing MEs, addresses this problem and has been
recognised as one of the cornerstones of patient safety.9,21
This study was undertaken as a ﬁrst step towards the
implementation of medication reconciliation at a teaching
hospital in Slovenia. The aim of the study was to provide
evidence of the need for medication reconciliation by
evaluating the number of discrepancies between patients’
pre-admission therapy and in-patient and discharge therapy
and evaluate their implications for patient care.
Materials and methods
Study design, settings and patients
The study was designed as a prospective, descriptive,
cross-sectional observational study, performed at a teaching
hospital, specialised in pulmonary and allergic diseases, in
Slovenia between August and October 2008. The study was
approved by the Institutional review board.
Each day, three patients were selected from the patients
admitted to a medical ward the previous day using a list
of random generated numbers. To be eligible, the patients
had to be over 18 years, had to be able to provide their
medication history in Slovenian and report the use of at
least one drug. Patients were asked to state their consent
to participate verbally. Patients admitted for allergy testing,
those discharged within three days from admission and those
who died during hospital stay, were excluded.
Data collection and evaluation
The selected patients were subjected to routine clinical
practice: the admitting clinician obtained a medication
history upon a patient’s admission and recorded it in the
hospital medical record as part of the admission process;
the recorded medication history could be revised when the
in-patient therapy was prescribed on the drug chart; and,
upon the patient’s discharge, the proposed drug therapy was
communicated to the patient’s GP through the discharge
letter.
In addition to routine clinical practice, for the purpose
of this study, accurate and complete information on
the pre-admission drug therapy was obtained for every
consenting patient by a research pharmacist. Using a
method recommended in the literature,5,22,23 information
on drug therapy was retrieved through a detailed patient
interview and the review of different sources of information
(the patient’s medications and own list of medicines, the
patient’s medical and pharmacy records, the patient and
carers if a patient had a poor recall of drug therapy). The
pharmacy record presents a list of all medicines that have
been dispensed to a patient in a community pharmacy.
Although the research pharmacist retrieved information on
the prescription and over-the-counter (OTC) medicines as
well as medicinal supplements and herbal preparations,
this article focuses on the prescription medicines only.
The information on pre-admission therapy retrieved by the
research pharmacist was proved in our previous research to
be more complete and more accurate than the one recorded
in the medical records12 and was, thus, used as a reference
for further comparisons.
Details on the in-patient and discharge therapy were
collected and compared with the pre-admission therapy to
identify any discrepancy. Any change to the pre-admission
therapy was identiﬁed as a discrepancy. Incomplete
drug orders, for example, a prescription order lacking
important information for the unambiguous identiﬁcation
and safe administration of a drug were also classiﬁed as a
discrepancy. There could be a number of discrepancies for
each drug, but only the most signiﬁcant for patient’s drug
treatment was recorded. The research pharmacist notiﬁed
the treating clinician about all discrepancies between
the pre-admission and the in-patient therapy, subsequent
changes to the drug therapy were done at the discretion
of the treating clinician and were not followed in this
study. The professional intention for each discrepancy
was determined by (i) consulting the treating clinician on
whether an in-patient drug discrepancy was committed
intentionally or unintentionally, and (ii) reviewing the
discharge letter to determine whether a discharge drug
discrepancy was intentional or unintentional. Unintentional
discrepancies were classiﬁed as MEs.
Rating the signiﬁcance of medication errors
The clinical signiﬁcance of MEs was determined through a
consensus of an expert panel of 3 pharmacists (2 hospital
pharmacists, 1 community pharmacist) and 3 clinicians (1
specialist in internal medicine, 1 surgeon, 1 GP). None of
the panellists was actively involved in the study. A modiﬁed
nominal consensus group method was used24: ﬁrst, the
panellists were asked to rate the signiﬁcance of the errors
using a four-point scale (0 = not important, 1 = important,
2 = very important, 3 = potentially fatal), then the individual
opinions were presented and discussed, and, ﬁnally, the
panellists were asked to rerate the errors (Table 3). In cases
where consensus was not reached with the second rating,
the median value of the ratings was recorded. The clinical
signiﬁcance was assessed for each ME separately; in cases
when a number of errors occurred in the treatment of one
patient, it was not possible to asses their cumulative impact
on patient care.
Data handling and statistical analysis
Conﬁdentiality and anonymity of patients and clinicians
were ensured throughout. The data were coded and
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Table 1
Characteristics of drugs in pre-admission therapy and their record
n/N %
Number of drugs in pre-admission therapya 625/625 100.0
ATC classiﬁcation of drugs in pre-admission therapy
ATC C 225/625 36.0
ATC N 102/625 16.3
ATC A 100/625 16.0
ATC R 66/625 10.6
ATC B 55/625 8.8
Other ATC classes 77/625 12.3
Drugs from pre-admission therapy recorded in the pharmacy record 526/625 84.2
Drugs from pre-admission therapy recorded in the medication history recorded
in the medical record
417/625 66.7
Complete records (the identiﬁcation of drug’s use is possible) 175/625 28.0
Inaccurate records (differ from pre-admission therapy) 446/625 71.4
ATC: Anatomical Therapeutic chemical Classiﬁcation; ATC C: Cardiovascular system; ATC N: Nervous system;
ATC A: Alimentary tract and metabolism; ATC R: Respiratory system; ATC B: Blood and blood forming organs.
a Information on patient’s pre-admission therapy was obtained by a research pharmacist, based on a detailed
patient interview in combination with different sources of information.
entered onto an SPSS version 14 database. In presenting
and analysing the data, patients were deﬁned as elderly
if over 65 years of age1 and medication errors whose
clinical signiﬁcance was rated as “important”, “very
important” or “potentially fatal” were termed as “clinically
important”. Patient data are presented as absolute
values and proportions. Median values and interquartile
ranges (IQR) are presented where appropriate. Differences
and associations were analysed using Chi-square, paired
t-test, independent sample t-test, ANOVA and Pearson’s
correlation, as appropriate. Values of p lower than 0.05 were
considered signiﬁcant.
Results
Patient characteristics and details on pre-admission
therapy
The study included 101 patients, most of whom were
elderly (median age: 73 years, IQR: 65–79) and male
(57.4%; 58/101). Patients were taking many drugs in
their pre-admission therapy (median: 6, IQR: 4–9). The
medicines’ distribution in the Anatomical Therapeutic
chemical Classiﬁcation (ATC) resembled the distribution of
medicines in the general Slovenian population.25 Most drugs
were recorded in the pharmacy record and in the medical
records (Table 1); however, the latter often proved to be
incomplete and inaccurate.
Medication errors in in-patient therapy
In the in-patient therapy, 74.3% (654/880) of the medicines
were in discordance with the patients’ pre-admission
therapy but most were intentional discrepancies (85.6%;
560/654; Table 2; Fig. 1). The expert panel rated over half of
the evaluable errors as clinically important (51.9%; Table 3).
At least one ME was recorded in 33.7 % (34/101) patients
and at least one clinically important ME in 18.8% (19/101)
of patients. One patient experienced as much as ﬁve errors,
four of which were determined clinically important.
The number of MEs in the in-patient therapy correlated
with the number of drugs in patients’ pre-admission therapy
(Pearson’s r = 0.558, p < 0.001) and with the number of
discrepancies in their medication history in the medical
record (Pearson’s r = 0.428, p < 0.001).
Medication errors in discharge therapy
At patients’ discharge, 75.8% (566) of the 747 prescribed
drugs were in discordance with patients’ pre-admission
therapy and most discrepancies (65.2%; 369/566) were
unintentional (Table 2; Fig. 1). The expert panel rated
58.0% (207/357) of the evaluable MEs as clinically important
(Table 3). Errors due to a discrepancy in the dose or drug
omission (Chi square, c2 = 75.496, df = 6, p < 0.001) and errors
in prescribing drugs from the ATC group C and less common
ATC groups (Chi square, c2 = 35.880, df = 5, p < 0.001) were
associated with greater clinical importance, indicating areas
in which special attention should be paid.
A median of three MEs were recorded per patient,
with the great majority of patients experiencing at least
one ME (84.2%; 85/101) and 71.3% (72/101) of patients
presenting with at least one clinically important ME. One
patient experienced as much as 11 MEs, all judged to have
potentially important clinical implications.
The number of MEs in the discharge therapy correlated
with patient age (Pearson’s r = 0.235, p = 0.018), number of
drugs in their pre-admission therapy (Pearson’s r = 0.660,
p < 0.001) and number of discrepancies in the recorded
medication history (Pearson’s r = 0.413, p < 0.001) or in
the in-patient therapy (Pearson’s r = 0.755, p < 0.001). Most
importantly, the same characteristics predisposed patients
to greater risk for clinically important discrepancies (drugs
in pre-admission therapy: Pearson’s r = 0.591, p < 0.001;
discrepancies in drug history: Pearson’s r = 0.437, p < 0.001;
discrepancies in in-patient therapy: Pearson’s r = 0.632,
p < 0.001).
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Table 2
Discrepancies and medication errors between pre-admissiona and in-patient therapy or discharge therapy,
respectively.
In-patient therapy
n/N %
Discharge therapy
n/N %
No. of discrepancies with pre-admission therapy 654/880 74.3 566/747 75.8
Reasons of recorded discrepancies
Drug commission 207/654 31.7 155/566 27.4
Drug omission 173/654 26.5 163/566 28.8
Discrepancy in drug’s dose 95/654 14.5 78/566 13.8
Drug substitution 92/654 14.1 83/566 14.7
Other 87/654 13.3 87/566 15.4
No. of medication errorsb 54/654 8.3 369/566 65.2
Reasons of recorded medication errors
Drug omission 34/54 63.0 149/369 40.4
Discrepancy in drug’s dose 14/54 25.9 58/369 15.7
Drug commission 2/54 3.7 66/369 17.9
Drug substitution 2/54 3.7 49/369 13.3
Other 2/54 3.7 47/369 12.7
Clinical importance of medication errors c
Not important 25/52 48.1 150/357 42.0
Important 18/52 34.6 186/357 52.1
Very important 9/52 17.3 20/357 5.6
Potentially fatal 0/52 0.0 1/357 0.3
a Information on patient’s pre-admission therapy was obtained by a research pharmacist, based on a detailed
patient interview in combination with different sources of information; this information was used for further
comparisons.
b An unintentional discrepancy was considered a medication error.
c The clinical signiﬁcance of certain medication errors could not be evaluated.
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Fig. 1. Presentation of the number of discrepancies, medication errors and clinical important medication errors in patient in-patient and
discharge therapy. A discrepancy was deﬁned as any difference in the in-patient or discharge therapy with the pre-admission therapy,
obtained by a research pharmacist, based on a detailed patient interview in combination with different sources of information. Amedication
error was deﬁned as any unintentional discrepancy.
Discussion
Our study provided evidence on the discontinuity of drug
therapy at times of patients’ transitions to and from
hospitals and its implications for the safety of patient
care. The presented results urge the implementation of
medication reconciliation practices throughout patient’s
hospital stay to ensure continuity of care and improve
patient safety.
Medication errors in in-patient therapy
In our study, over 75% of the drugs prescribed during
patient’s hospital stay were in discordance with patient’s
pre-admission therapy which is comparable to previously
published literature.5,7,10,11,17 However, this result is not
alarming since the large majority of the identiﬁed changes
were initiated intentionally by a clinician. The proportions
of unintentional discrepancies reported in the literature
vary (3.4%-75%),5,7,10,11,17; our ﬁndings reﬂect the results of
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Table 3
Examples of medication errors of different clinical importance
Clinical importance Therapy Example
Not important In-patient Patient (male, 62 years) was taking simvastatin tbl 40mg once daily before hospital admission; no
similar drug was prescribed during hospital stay.
Discharge Patient (male 76 years) was taking simvastatin tbl 40mg once daily before hospital admission;
another brand of simvastatin was prescribed in the discharge therapy.
Important In-patient Patient (female, 74 years) was taking theophylline SR cps 200mg once daily before hospital
admission; theophylline SR cps 200mg twice daily was prescribed during hospital stay.
Discharge Patient (male, 84 years) was taking atorvastatin tbl 10mg once daily before hospital admission;
atorvastatin tbl 40mg once daily was prescribed at discharge.
Very important In-patient Patient (male, 76 years) was taking aspirin GR tbl 100mg once daily before hospital admission; no
similar drug was prescribed during hospital stay.
Discharge Patient (male, 75 years) was taking metildigoxin tbl 0.1mg once daily before hospital admission;
the drug was not mentioned in the discharge therapy.
Potentially fatal In-patient No example of this clinical signiﬁcance was recorded.
Discharge Patient (male, 15 years) with cystic ﬁbrosis was taking azithromycin tbl 250mg three days a week
on a regular basis before hospital admission; the drug was not mentioned in the discharge therapy.
tbl: tablet; SR cps: slow release capsules; GR tbl: gastro-resistant tablets.
those studies where the treating clinician determined the
discrepancies’ intention. In these studies, the proportion
of unintentional discrepancies may be underestimated as
the clinician may have been biased when indicating that a
discrepancy was intended.
In our study, nearly one ﬁfth of patients experienced
at least one clinically important ME, reﬂecting other
studies.5,13,17 Patients taking more medicines prior to
hospital admission were shown, in our and other studies,
to experience more MEs in their in-patient therapy.7,17
Moreover, a similar correlation was found with the number
of inaccuracies in the medication history recorded in
the medical record. In fact, drug histories in medical
records often do not provide complete and accurate
information on patient’s pre-admission therapy;12,14,15,17
similar observations were made also in our study. Accurate
and comprehensive medication histories should be aspired
at all times as inaccuracy may lead to MEs in later stages of
patient treatment.
In summary, in-patient therapy was characterised by a
relatively low number of clinically important MEs, most
originated from incomplete and inaccurate medication
history taking.
Medication errors in discharge therapy
The results of our study identiﬁed a patient’s discharge
from hospital as a critical point in ensuring continuity and
safety of care. Our results are similar to those of studies
evaluating continuity of care in environments where no
medication reconciliation was implemented.10 Although a
lower proportion of MEs (around 25%) and patients suffering
at least one ME (from 14 to 41%) was reported in settings
where medication reconciliation practices were established
at admission,10,11,13 their continued presence indicates the
need for medication reconciliation at patient’s discharge
regardless of its use at time of a patient’s admission.
Of even greater importance, MEs at patient discharge
are not only very frequent but carry a great potential
for detrimental effect on patient care. As the clinical
signiﬁcance was rated for each drug separately, their true
impact on patient care may be underestimated in patients
with more discrepancies and more serious consequences
may be expected e.g. in the patient experiencing 11
clinically important MEs. Our results are not alone in
demonstrating the importance of medication reconciliation
at hospital discharge for intercepting clinically important
MEs,13 and reducing the rate of ADEs and hospital
utilization.8,16
Our and previous research identiﬁed patient age4,11,26
and number of drugs in pre-admission therapy4,26 as risk
factors for ME and ADE; additional attention should be
paid in drug management of these patients. Patients
with more discrepancies in their medication history and
in-patient therapy experienced more MEs and clinically
important MEs at discharge from hospital. The importance
of rectifying discrepancies in drug therapy as soon as they
occur was evidenced also by other researchers: admission
discrepancies were associated with the number of MEs at
patient discharge11 and many MEs occurring at time of
hospital discharge were found to originate from a poor
medication history.6,10
Overall, a patient discharge therapy was characterised
by a high number of clinically important MEs, evidencing
patient discharge as a critical point in ensuring continuity
of care. To tackle this problem, a comprehensive approach
is needed: accurate drug histories should be aspired
at all times as well as medication reconciliation at
admission and discharge should be employed. Since
medication reconciliation is a time demanding process,13
it should be implemented within a study framework,
evaluating its beneﬁts over routine practice and estimating
the associated workload. Moreover, the competence of
medication reconciliation providers is of utmost importance:
among all healthcare providers, pharmacists have been
shown to provide most complete and accurate drug histories
and perform best at medication reconciliation;7,10,13,23,27
their participation in medication reconciliation would make
the best use of the expertise of different healthcare
professionals.
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Strengths and limitations
Studies evaluating the need for medication reconciliation
are often limited only to certain error types4 and only few
studies evaluated the need for medication reconciliation
across the entire patient episode.6,13,28 Moreover, other
studies often introduced biases in determining the discrep-
ancies’ intention and their clinical signiﬁcance by relying
on the judgement of only few healthcare professionals,
often actively participating in the study.4,10,13,14 All these
limitations were addressed in designing our study.
However, the study presents some limitations. It was
limited to one hospital in Slovenia and although the results
cannot be generalized to other settings, it is the ﬁrst study
to address this issue in Slovenia. The method used to obtain
the information on pre-admission therapy was taken from
the literature without further revalidation; this limitation
was accepted since it was showed in our previous research to
be more complete and more accurate than the medication
history recorded in the medical records.12 The number of
unintentional discrepancies in in-patient therapy may be
underestimated as the treating clinician may have had a
bias to indicate that a discrepancy was intended. And,
ﬁnally, although the study provided objective estimations
of the clinical signiﬁcance of the identiﬁed MEs, the ADEs
experienced by the patients should be assessed in further
studies.
Conclusions
The results of our study urge the implementation of
medication reconciliation practices to improve patient
safety: admission and discharge from hospitals were shown
to produce a large number of discrepancies in patients’
drug therapy, many of which represent MEs with important
implications for patient care. Although patients’ discharge
was characterised by more MEs, discrepancies and errors
in the medication history and in in-patient therapy led
to a higher number of errors in further steps; to ensure
continuity of patient care, medication reconciliation should
be implemented throughout patients’ hospital stay.
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